ImpediMed Limited is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status. ImpediMed’s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm and leg in female and male cancer patients.
Company’s Keywords:
lymphedema, fluid status, body composition, tissue analysis
92
medical devices
4800000
Cloudflare DNS, MailJet, Outlook, MailChimp SPF, Google Cloud Hosting, Microsoft Dynamics 365 Marketing, WP Engine, YouTube, WordPress.org, Nginx, Gravity Forms, Google Tag Manager, Facebook Widget, Mobile Friendly, reCAPTCHA, Facebook Login (Connect), Google Analytics
1999